Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.
|Articles|November 2, 2019
- Pharmaceutical Technology-11-02-2019
- Volume 43
- Issue 11
Highest Shear Mixer Available
MegaShear from Ross is a patented ultra-high shear rotor/stator mixer for high-throughput emulsification, dispersion, and homogenization.
MegaShear from Ross is a patented ultra-high shear rotor/stator mixer for high-throughput emulsification, dispersion, and homogenization. The device features 11,300 ft/min tip speed and can reach a level of shear typically only seen in high-pressure homogenizers.
The MegaShear Model HSM-706M-50 (pictured) comes equipped with a 50HP motor for creating high-quality dispersions, suspensions, and emulsions for the food, cosmetic, pharmaceutical and nutraceutical, chemical, coatings, electronics, and composites industries. The MegaShear is also less sensitive to clogging and changes in viscosity compared to high-pressure homogenizers.
Articles in this issue
almost 7 years ago
QbD Takes Shape for Topical Pharmaceuticalsalmost 7 years ago
Optimizing Compression Coating for Pulsatile Release Tabletsalmost 7 years ago
Advancing Transdermal Drug Deliveryalmost 7 years ago
The Emergence of Operational Technology as a Servicealmost 7 years ago
Residual Moisture Determination in Lyophilized Drug Productsalmost 7 years ago
Powder Dosing Unitalmost 7 years ago
Innomech Benchtop Systemsalmost 7 years ago
Automated Cotton Inserteralmost 7 years ago
The Right Pieces for a Quality Programalmost 7 years ago
More Consistent Drug Inspection System on HorizonRelated to this article
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Jaenisch, Muraru, and Pandey discuss new skills for QC and regulatory teams, plus patient trust, as new approach methodologies reshape pharma.
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
Trending on Pharmaceutical Technology
1
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
2
Nitrosamine Problems and Industry Solutions: PharmTech Explained
3
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
4
FDA Approves Bepirovirsen: Why Oligonucleotide CDMOs Should Take Note
5